Home

Concord Biotech Ltd Quarterly Result

Image

Concord Biotech Ltd

NSE: CONCORDBIO

Net Profit - Last Quarter

₹ 140.39 Cr.

Last updated on: Jul 02, 2025

Concord Biotech Ltd Quarterly Results Key Highlights

  • The revenue of Concord Biotech Ltd for the Mar '25 is ₹ 439.27 crore as compare to the Dec '24 revenue of ₹ 260.78 crore.
  • This represent the growth of 68.44%a1# The ebitda of Concord Biotech Ltd for the Mar '25 is ₹ 198.26 crore as compare to the Dec '24 ebitda of ₹ 114.51 crore.
  • This represent the growth of 73.14%a1# The net profit of Concord Biotech Ltd for the Mar '25 is ₹ 140.39 crore as compare to the Dec '24 net profit of ₹ 75.92 crore.
  • This represent the growth of 84.92%a1#.

Concord Biotech Ltd Quarterly Results Analysis

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Jul 20251757.35
01 Jul 20251797.2
30 Jun 20251848.85
27 Jun 20251825.15
26 Jun 20251797.15
25 Jun 20251814.05
24 Jun 20251780.75
23 Jun 20251822.5
20 Jun 20251840.05
19 Jun 20251968.55

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Concord Biotech Ltd News Hub

Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against

Read more

09 Aug 24

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst

Read more

29 Aug 24

Concord Biotech to announce Quarterly Result

Concord Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powered

Read more

24 May 25

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow

Read more

06 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for Quarterly Results of Concord Biotech Ltd

What key financial metrics are included in Concord Biotech Ltd's quarterly results?

Key financial metrics in Concord Biotech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Concord Biotech Ltd announce its quarterly results?

Concord Biotech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Concord Biotech Ltd's quarterly performance impact its stock price?

Concord Biotech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Concord Biotech Ltd's quarterly results on dividends?

The impact of Concord Biotech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Concord Biotech Ltd's quarterly results?

Yes, Concord Biotech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions